ClinicalTrials.Veeva

Menu

A Comparison of Etomidate and Ketamine for Anesthesia Induction in Coronary Artery Bypass Graft Surgery

B

Baskent University

Status and phase

Unknown
Phase 4

Conditions

Coronary Artery Bypass Surgery

Treatments

Drug: Etomidate
Drug: Ketamine

Study type

Interventional

Funder types

Other

Identifiers

NCT01386229
KA-10-114

Details and patient eligibility

About

The aim of this study is to determine whether ketamine is an acceptable alternative to etomidate for anesthesia induction in coronary artery bypass graft surgery in terms of hemodynamic stability and also to compare these agents regarding their effect on adrenal gland steroid synthesis in these patients.

Enrollment

40 estimated patients

Sex

All

Ages

30 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients scheduled for elective coronary artery bypass graft surgery with cardiopulmonary bypass
  • Patient's written informed consent for study participation
  • Ejection fraction ≥ 35%

Exclusion criteria

  • Allergy to study drugs
  • Redo surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

40 participants in 2 patient groups

Ketamine
Active Comparator group
Treatment:
Drug: Ketamine
Etomidate
Active Comparator group
Treatment:
Drug: Etomidate

Trial contacts and locations

1

Loading...

Central trial contact

Arash Pirat; Özgür Kömürcü

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems